Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Case history - chief complaint
- Case history - recent history
- Case history - physical exam
- Case history - initial treatment
- Outline - prevention
- The best management is prevention
- Preventive strategies
- Traffic-light model: green/yellow/red zones
- Peak flow meter with adjustable markers
- Asthma action plan - example
- Outline - assessment
- Patient assessment
- Risk factors for severe, potentially fatal asthma
- Physical findings in severe asthma attacks
- Lung function measurements
- Chest X-ray is of limited value
- Role of arterial blood gases
- Lung function & PCO2 in acute, severe asthma
- Outline - treatment
- Treatment of acute asthma - overview
- Principles of care for acute asthma
- Initial treatment - comparison of three regimens
- Initial treatment
- MDI and nebulizer equivalence
- MDI with spacer vs. nebulizer in severe disease
- Inhaled beta-agonists in acute asthma
- Patterns of response to albuterol
- Additional bronchodilators in acute, severe asthma
- Intravenous magnesium - meta-analysis
- Intravenous magnesium - randomized trial
- Helium-oxygen mixture (Heliox) (1)
- Helium-oxygen mixture (Heliox) (2)
- Helium-oxygen mixture (Heliox) (3)
- Bronchodilator failure - probable causes
- Steroids in acute, severe asthma
- Systemic steroids during hospitalization
- Oral steroids on emergency dept. (E.D.) discharge
- Intramuscular steroids on E.D. discharge
- Inhaled steroids following E.D. discharge (1)
- Inhaled steroids following E.D. discharge (2)
- Optimal dose of systemic steroids - unknown (1)
- Optimal dose of systemic steroids - unknown (2)
- Oral vs. intravenous corticosteroids
- Optimal duration of systemic steroids - unknown
- No need for oral steroid "taper"
- The outpatient "steroid burst"
- Antibiotics for acute, severe asthma
- Other therapies of unproven/unlikely benefit
- Outline - disposition
- Rationale for in-hospital treatment
- Indications for admission
- Unconventional therapies in acute, severe asthma
- Indications for intubation & mechanical ventilation
- Discharge criteria
- Patient education prior to hospital discharge
- Conclusions
- Summary
- Thank you
Topics Covered
- Asthma prevention, assessment, treatment and disposition
- Risk factors and physical findings in severe asthma attacks
- Treatments: Steroids, MDI, Nebulizer, Beta-agonists, Bronchodilators, Magnesium, Heliox & Antibiotics
- Unproven and unconventional therapies
- Rationale for in-hospital treatment and indications for admission
- Indications for intubation & mechanical ventilation
- Discharge criteria and patient education prior to hospital discharge
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fanta, C. (2013, January 24). Management of acute exacerbations of asthma [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 11, 2024, from https://doi.org/10.69645/UKAU9201.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Chris Fanta has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.